转移性肾盂移行细胞癌
| 药物 | 药物名称 | 药物的描述 |
|---|
| 药物 | 药物名称 | 目标 | 类型 |
|---|
| 药物 | 药物名称 | 阶段 | 状态 | 数 |
|---|---|---|---|---|
| DB08875 | Cabozantinib | 1 | 积极不招聘 | 1 |
| DB13007 | Enfortumab vedotin | 1 | 招聘 | 1 |
| DB12147 | Erdafitinib | 1 | 招聘 | 1 |
| DB06186 | Ipilimumab | 1 | 积极不招聘 | 1 |
| DB09035 | Nivolumab | 1 | 积极不招聘 | 1 |
| DB00041 | Aldesleukin | 2 | 撤销 | 1 |
| DB11595 | Atezolizumab | 2 | 积极不招聘 | 1 |
| DB11595 | Atezolizumab | 2 | 招聘 | 1 |
| DB00531 | 环磷酰胺 | 2 | 撤销 | 1 |
| DB08871 | Eribulin | 2 | 招聘 | 1 |
| DB01073 | 氟达拉滨 | 2 | 撤销 | 1 |
| DB11997 | 白介素- 7 | 2 | 积极不招聘 | 1 |
| DB06186 | Ipilimumab | 2 | 招聘 | 1 |
| DB17107 | Lifileucel | 2 | 撤销 | 1 |
| DB09035 | Nivolumab | 2 | 没有招聘 | 1 |
| DB09035 | Nivolumab | 2 | 招聘 | 1 |
| DB09037 | Pembrolizumab | 2 | 招聘 | 1 |
| DB09037 | Pembrolizumab | 2 | 撤销 | 1 |
| DB00571 | 普萘洛尔 | 2 | 招聘 | 1 |
| DB06273 | 叫 | 2 | 招聘 | 1 |
| DB11595 | Atezolizumab | 3 | 招聘 | 1 |
| DB11945 | Avelumab | 3 | 招聘 | 2 |
| DB00112 | 贝伐单抗 | 3 | 完成 | 1 |
| DB08875 | Cabozantinib | 3 | 招聘 | 1 |
| DB14547 | 氯离子 | 3 | 完成 | 1 |
| DB00515 | 顺铂 | 3 | 完成 | 1 |
| DB01248 | 多烯紫杉醇 | 3 | 招聘 | 1 |
| DB11714 | Durvalumab | 3 | 招聘 | 1 |
| DB08871 | Eribulin | 3 | 招聘 | 1 |
| DB00441 | 吉西他滨 | 3 | 完成 | 1 |
| DB00441 | 吉西他滨 | 3 | 招聘 | 1 |
| DB09035 | Nivolumab | 3 | 招聘 | 1 |
| DB01229 | 紫杉醇 | 3 | 招聘 | 1 |
| DB09037 | Pembrolizumab | 3 | 招聘 | 1 |
| DB12257 | 铂 | 3 | 完成 | 1 |